Molecular dissection of the human A 3 adenosine receptor coupling with β-arrestin2

• Published in: Biochemical pharmacology Vol. 148; pp. 298 - 307
• Main Authors: Storme, Jolien, Cannaert, Annelies, Van Craenenbroeck, Kathleen, Stove, Christophe P
• Format: Journal Article
• Language: English
• Published: England 01-02-2018
• Subjects: Adenosine - analogs & derivatives; Adenosine - pharmacology; Adenosine A3 Receptor Agonists - pharmacology; beta-Arrestin 2 - metabolism; Gene Expression Regulation - drug effects; Genetic Complementation Test; HEK293 Cells; Humans; Mutation; Receptor, Adenosine A3 - metabolism; β-Arrestin2; Live-cell reporter assay; A adenosine receptor; Nanoluciferase; Functional complementation
• ISSN: 0006-2952; 1873-2968
• DOI: 10.1016/j.bcp.2018.01.008

Besides classical G protein coupling, G protein-coupled receptors (GPCRs) are nowadays well known to show significant signalling via other adaptor proteins, such as β-arrestin2 (βarr2). The elucidation of the molecular mechanism of the GPCR-βarr2 interaction is a prerequisite for the structure-activity based design of biased ligands, which introduces a new chapter in drug discovery. The general mechanism of the interaction is believed to rely on phosphorylation sites, exposed upon agonist binding. However, it is not known whether this mechanism is universal throughout the GPCR family or if GPCR-specific patterns are involved. In recent years, promising orally active agonists for the human A
adenosine receptor (A
AR), a GPCR highly expressed in inflammatory and cancer cells, have been evaluated in clinical trials for the treatment of rheumatoid arthritis, psoriasis, and hepatocellular carcinoma. In this study, the effect of cytoplasmic modifications of the A
AR on βarr2 recruitment was evaluated in transiently transfected HEK293T cells, using a live-cell split-reporter system (NanoBit®, Promega), based on the structural complementation of NanoLuc luciferase, allowing real-time βarr2 monitoring. The A
AR-selective reference agonist 2-Cl-IB-MECA yielded a robust, concentration dependent (5 nM-1 µM) recruitment of βarr2 (logEC50: -7.798 ± 0.076). The role of putative phosphorylation sites, located in the C-terminal part and cytoplasmic loops, and the role of the 'DRY' motif was evaluated. It was shown that the A
AR C-terminus was dispensable for βarr2 recruitment. This contrasts with studies in the past for the rat A
AR, which pointed at crucial C-terminal phosphorylation sites. When combining truncation of the A
AR with modification of the 'DRY' motif to 'AAY', the βarr2 recruitment was drastically reduced. Recruitment could be partly rescued by back-mutation to 'NQY', or by extending the C-terminus again. In conclusion, other parts of the human A
AR, either cytosolic or exposed upon receptor activation, rather than the C-terminus alone, are responsible for βarr2 recruitment in a complementary or synergistic way.